Please read our student and staff community guidance on COVID-19
Skip to main content Skip to navigation

Applied Biomedical Technologies

ABT

Drawing on particular strengths of the University of Warwick and Hospital partners in Engineering, Biomaterials and Digital technologies, these studentships offer the opportunity to students from a range of scientific backgrounds to undertake a one year MSc in Interdisciplinary Biomedical Research and an exciting three year PhD project in applied biomedical technologies at the translational interface between academia and the clinic. Research areas include digital pathology, point-of-care diagnostics, biomedical engineering, biosensors, nano-biotechnology, polymer chemistry and small animal in vivo and clinical imaging. Visit the following sites for more information:


Exemplar projects

  • Andrew Blanks (Medical School) and Jan Brosens (WMS, University Hospital Coventry and Warwickshire) | Development of second generation oxytocin antagonists for preterm labour
  • Nigel Burroughs (Mathematics Institute) and Till Bretschneider (Computer Science) | Development of advanced computational tools and algorithms to analyze large-scale imaging datasets.
  • Jerome Charmet (WMG) l Development of microfluidic based platforms for biosensing and studies of complex biological processes | see Kartanas et al. Anal. Chem., 2017. | working with Robert Dallmann (Medical School), Mark Barrow, David Haddleton (Chemistry), James Covington, Julian Gardner (Engineering), Antonia Sagona (SLS), Greg Gibbons, Mark Elliott (WMG).
  • Nicholas Dale (Life Sciences) and Chris Imray (University Hospital Coventry and Warwickshire) | Analytical tools for neuroscience including development of point-of-care diagnostic biosensors.
  • Robert Dallmann (Medical School) and Robert Huckstepp (Life Sciences) | Novel in vivo animal imaging technologies for chronotherapy and treatment of sleep apnoea.
  • Christopher Dowson, David Roper (Life Sciences) and Tim Bugg (Chemistry) | Discovery of novel antimicrobials for the peptidoglycan cell wall synthesis pathway in multidrug resistant bacteria. Multiple interactions with industry through the recently awarded Medicines Discovery Catapult.
  • Mark Elliott (WMG) l Data analysis, signal processing and modelling of human movement and activity for health applications including rehabilitation, pre-surgical assessment and recovery monitoring/prediction. | working with Prof Richard King (UHCW), Dr Andrew Metcalfe (WMS), Dr Jerome Charmet (WMG).
  • Matt Gibson (Chemistry and Medical School) l Cell, tissue and biologic storage, point of care sensors and new antimicrobials, using carbohydrate, materials and synthetic biologies. l Gibson et al, Polymer mimics of biomacromolecular antifreezes, Nature Communications, 2017, 1546 l working with Dr Elizabeth Fullam (SLS) and Dr Nick Waterfield (WMS)
  • Vishwesh Kulkarni (Engineering) l Theoretical Approaches and Technologies for Disease Diagnosis and Therapy Interventions. l working with NHS partners in Coventry and with industry partners such as Agilent, Medtronic, Pfizer, L’Oreal, Microsoft Research, and others.
  • Neophytos Neophytou (Engineering) Theoretical investigations of the electronic, thermal, thermoelectric, optical, etc. properties of nanomaterials and nanodevices for various applications. l N. Neophytou, Prospects of low-dimensional and nanostructured silicon-based thermoelectric materials: Findings from theory and simulation, European Physical Journal B, 88, 86, 2015
  • Sebastien Perrier (Chemistry and Medical School) | Synthesis of nano-structured materials for drug delivery, bio-conjugation and synthetic vaccines.
  • Nasir Rajpoot (Computer Science) l and David Snead (University Hospital Coventry Warwickshire) | Development of novel machine learning algorithms for digital pathology.
  • Tara Schiller (WMG) l Characterisation of human tissue degradation and mechanisms of change through materials characterisation l Htun, N. M., et. Al. 2017. Nat. Commun., 8 (1) l working with Prof Matt Gibson, Asst Prof Jerome Charmet and Prof Karlheinz Peter, Baker ID.
  • David Spanswick (Medical School and Monash University) l Preclinical drug discovery for pain, neuro-degeneration and psychiatry by studying electrophysiology of the nervous system.

Key Facts

Four-year MSc + PhD fully funded programme

Contact: Sally Blakeman

Email: mrcdtp at warwick dot ac dot uk

Telephone: 024 7652 3913

Apply here 

Funding